Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV albumin before rescue infliximab in acute severe ulcerative colitis
ACTRN12619001081101Phase 2Not yet recruiting
- Sponsor
- The Alfred Hospital
- Start
- Oct 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in autoimmune colitis comparing Albumin prior to infliximab with Placebo saline prior to infliximab (2 arms). Primary endpoint: Infliximab pharmacokinetics. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
albumin (human)infliximab
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on ACTRN12619001081101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001081101.